期刊文献+

细胞DNA倍体分析与常规细胞学诊断对宫颈上皮内瘤变诊断评估的比较

Comparative Analysis of Diagnosis and Evaluation of Cervical Epithelial Neoplasia by Cell DNA Double Body Analysis and Conventional Cytological Diagnosis
下载PDF
导出
摘要 目的研究细胞DNA倍体分析与常规细胞学诊断对宫颈上皮内瘤变诊断评估效果。方法选取2016年3月—2017年3月期间来本院行细胞DNA倍体分析和常规细胞学诊断的140例患者,其中可疑阳性患者26例,所有患者全部进行病理组织检验,对比两组检验方法的灵敏性。结果本次研究的常规细胞学诊断灵敏度为:22.2%、特异性:75.0%,DNA倍体分析诊断的灵敏度:77.8%,特异性:91.7%,比较常规细胞学与DNA倍体分析的诊断灵敏度,对比数据差异性显著,统计学意义存在(χ2=5.5556,P<0.0184)。结论宫颈上皮内瘤变诊断中,DNA倍体分析的诊断灵敏度显著高于常规细胞学诊断,所以DNA倍体分析的诊断效果更好,不但可以应用在宫颈上皮内瘤变诊断中,还能够判断宫颈上皮内瘤变的发展趋势,值得临床广泛推广。 Objective To study the effect of cell DNA double body analysis and conventional cytology diagnosis on cervical intraepithelial neoplasia. Methods Forty patients with DNA doubling analysis and routine cytology diagnosed from March,2016 to March,2017 in our hospital were selected,including 26 suspicious positive patients and all the patients were pathologically tested,and compared with two test methods Sensitivity. Results The study of the sensitivity to conventional cytology diagnosis:22.2%,specificity:75.0%,DNA times body analysis,the sensitivity of diagnosis:77.8%,specificity:91.7%,comparing to conventional cytology and DNA times analysis. The diagnostic sensitivity of boundary of comparative data exist(χ~2=5.5556,P<0.0184). Conclusion In the diagnosis of cervical intraepithelial neoplasia,the diagnostic sensitivity of DNA ploidy analysis is significantly higher than conventional cytological diagnosis,so the DNA ploidy analysis of the diagnosis is better,not only can be used in the diagnosis of cervical intraepithelial neoplasia,but also to determine the development trend of cervix intraepithelial neoplasia. It is widely clinical promotion.
作者 骆青荣
出处 《大医生》 2017年第8期52-53,共2页 Doctor
关键词 DNA倍体分析 常规细胞学诊断 宫颈上皮内瘤变 DNA double body analysis conventional cytological diagnosis cervical intraepithelial neoplasia
  • 相关文献

参考文献6

二级参考文献57

  • 1孙小蓉,车东媛,涂洪章,李丹,汪键.细胞DNA倍体分析评估宫颈上皮内瘤变[J].中华肿瘤杂志,2006,28(11):831-835. 被引量:19
  • 2史娅萍,朱宇宁,周丽琴,崔卫东.人乳头瘤状病毒基因型在宫颈疾病中的分布特点[J].中华检验医学杂志,2007,30(9):1009-1012. 被引量:30
  • 3Mclachlin CM. Human papillomavirus in cervical neoplasia. Role,risk factors, and implications. Clin Lab Med ,2000,20 :257-270.
  • 4Friedek D,Ekiel A, Chelmicki Z, et al. HPV Chlamydiatrachomatis and genital mycoplasmas infections in women withlow-grade squamous intraepitheliai lesions ( LSIL) . Ginekol Pol,2004,75:457^63.
  • 5Clavel C’Masure M ,Bory JP,et al. Human papillomavirus testingin primary screening for the detection of high grade cervical. 1.esions : A study of 7 932 women. Br J Cancer, 2001,84 :1616-1623.
  • 6Molijn A, Kleter B, Quint W, et al. Molecular diagnosis of human papillomavirus (HPV) infections[J]. J Clin Virol, 2005, 32(3): 43-51.
  • 7Wright TC, Stoler MH, Behrens CM, et al. The ATHENA human papillomavirus study : design, methods, and baseline results [ J ]. Am J Obstet Gynecol, 2012, 206( 1 ) : 46. e1-46, e11.
  • 8Rao A, Sandri MT, Sideri M, et al. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas HPV Test results from the ATHENA study[J]. J Clin Virol, 2013, 58( 1 ) : 161-167.
  • 9Wen C, Xun Z, Molijn A, et al. Human papillomavirus type-distri- bution in cervical cancer in China: the importance of HPV 16 and 18 [ J ]. Cancer Cause Control, 2009, 20 (9) : 1705-1713.
  • 10Yongjung P, Eunhee L, Jonghyeon C, et al. Comparison of the Ab- bott RealTime High-Risk Human Papillomavirus (HPV) , Roche Co- bas HPV, and Hybrid Capture 2 assays to direct sequencing and geno- typing of HPV DNA. [ J]. J Clin Microbiol, 2012, 50 (7) : 2359- 2365.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部